Literature DB >> 22608029

Transient myopic shift after phakic intraocular lens implantation.

Jose L Güell1, Merce Morral, Oscar Gris, Daniel Elies, Felicidad Manero.   

Abstract

UNLABELLED: Three patients presented with spontaneous myopic shift 6 weeks to 6 months after implantation of the Artiflex phakic intraocular lens (pIOL). The corrected distance visual acuity (CDVA) was maintained in all cases. Cyclopentolate drops successfully reverted the myopic shift in all cases; however, 2 cases required surgical reenclavation of the pIOL haptics to achieve long-term refractive stability. At the last follow-up, all patients had returned to emmetropia, with uncorrected distance visual acuities of 20/20. A slight decrease in objective optical quality was observed. No eye lost a line of CDVA. In 1 eye, optical coherence tomography scans showed slight posterior positioning of the pIOL. These cases show that spontaneous myopic shift is a potential complication of iris-claw pIOL implantation. That cyclopentolate drops and/or reenclavation of the haptics were effective in reverting the situation suggests a mechanical mechanism related to iris and ciliary body dynamics. FINANCIAL DISCLOSURE: Dr. Güell is a consultant to Ophtec. No author has a financial or proprietary interest in any material or method mentioned.
Copyright © 2012 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22608029     DOI: 10.1016/j.jcrs.2012.04.020

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  2 in total

1.  [Transient visual deterioration by exposure to cold, phacic anterior chamber lens and forme fruste keratoconus. How can this be explained?].

Authors:  E-M Faschinger; C Faschinger
Journal:  Ophthalmologe       Date:  2014-03       Impact factor: 1.059

2.  Engineering a Light-Attenuating Artificial Iris.

Authors:  Farah J Shareef; Shan Sun; Mrignayani Kotecha; Iris Kassem; Dimitri Azar; Michael Cho
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04-01       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.